Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-28

FDA Approved: PROCHLORPERAZINE EDISYLATE — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved the original application for Prochlorperazine Edisylate as a generic antiemetic indicated for relief of nausea and vomiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prochlorperazine edisylate (Prochlorperazine edisylate)

Snippet

ORIG AP for PROCHLORPERAZINE EDISYLATE (PROCHLORPERAZINE EDISYLATE)